Innogenetics Court Likens Royalty Award To License

Law360, New York (March 7, 2008, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit recently addressed a multitude of issues and vacated an injunction against Abbott Laboratories while upholding in part a ruling that Abbott infringed an Innogenetics patent for detecting and classifying hepatitis C virus genotypes. Innogenetics, N.V. v. Abbott Laboratories, Case Nos. 07-1145, -1061 (Fed. Cir., Jan. 17, 2008) (Moore J.).

Innogenetics’ patent claims a method of genotyping hepatitis C virus (HCV) based on distinct genetic sequences that can be found in the 5 prime untranslated region (5' UTR)...
To view the full article, register now.